As of 2025-07-23, the EV/EBITDA ratio of Eastwood Bio-Medical Canada Inc (EBM.V) is -102.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EBM.V's latest enterprise value is 33.47 mil CAD. EBM.V's TTM EBITDA according to its financial statements is -0.33 mil CAD. Dividing these 2 quantities gives us the above EBM.V EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.5x - 4.6x | 3.6x |
| Forward P/E multiples | 3.7x - 5.7x | 4.7x |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -103.9% - -104.7% | -104.2% |
| Date | EV/EBITDA |
| 2025-04-30 | -127.32 |
| 2025-04-22 | -116.73 |
| 2025-04-16 | -119.38 |
| 2025-04-14 | -118.05 |
| 2025-04-11 | -106.13 |
| 2025-04-10 | -106.13 |
| 2025-04-09 | -108.78 |
| 2025-04-08 | -91.57 |
| 2025-04-07 | -91.57 |
| 2025-04-03 | -124.67 |
| 2025-03-25 | -95.54 |
| 2025-03-18 | -106.13 |
| 2025-03-17 | -92.89 |
| 2025-03-12 | -106.13 |
| 2025-03-11 | -108.78 |
| 2025-03-10 | -111.43 |
| 2025-02-28 | -156.46 |
| 2025-02-25 | -120.70 |
| 2025-02-19 | -119.38 |
| 2025-02-18 | -110.11 |
| 2025-02-14 | -114.08 |
| 2025-02-11 | -119.38 |
| 2025-02-05 | -132.62 |
| 2025-02-03 | -132.62 |